Navigation Links
Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 - ESMO 34 Congress
Date:9/16/2009

THOUSAND OAKS, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced it will present detailed data from four Phase 3 studies as well as other data at the ECCO 15 - ESMO 34 European Multidisciplinary Congress, September 20 - 24, 2009 in Berlin, Germany.

Researchers will present data from two Phase 3 head-to-head studies evaluating denosumab versus Zometa(R) (zoledronic acid) for the treatment of bone metastases in patients with advanced breast cancer (the '136' study) and the treatment of bone metastases in advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma (the '244' study).

Detailed data will also be presented from two Phase 3 studies evaluating Vectibix(R) (panitumumab) in combination with chemotherapy for the first-line and second-line treatment of metastatic colorectal cancer (the '203' and '181' trials, respectively).

"Amgen is very pleased to be presenting these important data from the denosumab and Vectibix development programs," said Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen. "The data from these trials demonstrate that both denosumab and Vectibix have the potential to improve outcomes in patients suffering from cancer."

SELECTED ABSTRACTS OF INTEREST

Identified below are selected abstracts of interest on Amgen research. Updated data will be presented at the meeting.

    Denosumab
    --  A double-blind, randomized study of denosumab versus zoledronic acid
    for the treatment of bone metastases in patients with advanced cancer
    (excluding breast and prostate cancer) or multiple myeloma
        Lead Author: Henry, D.
        Abstract No. 20L
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
3. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
4. Amgen to Present at the Barclays Capital Global Healthcare Conference
5. Amgen Announces Webcast of 2009 First Quarter Financial Results
6. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
7. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
8. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
9. Amgen Highlights Data to Be Presented at ASCO
10. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
11. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... The International and American Associations for Dental Research (IADR/AADR) ... Prevalence Following Five Decades of Decline." This study, by ... Chapel Hill, USA, follows edentulism (tooth loss) over the ... losing teeth and requiring dentures. It is published in ... Dental Research ( JDR ). , The ...
(Date:8/21/2014)... United Benefit Advisors (UBA), the ... pleased to announce Trinity Benefit Advisors as its ... Trinity Benefit Advisors is a full service firm ... clients. Their consultative approach is comprised of four ... and monitoring. Their dedication to effective results and ...
(Date:8/21/2014)... York (PRWEB) August 21, 2014 According ... Research "Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral ... - Global Industry Analysis, Size, Share, Growth, Trends and ... was valued at USD 2.0 billion in 2012 and ... 3.1 billion in 2019growing at a CAGR of 6.2% ...
(Date:8/21/2014)... authorities need to ensure that experimental drugs to treat ... randomized controlled trials, according to a new Viewpoint, published ... 2014]. , Leading bioethicists Professor Ezekiel Emanuel, ... Annette Rid, of King,s College London, UK, outline critical ... experimental drugs are to be deployed in the Ebola ...
(Date:8/21/2014)... Albany, NY (PRWEB) August 21, 2014 ... 2020 - Novel Therapeutic Approaches Target High Unmet ... provides in-depth analysis of the Glioblastoma Multiforme (GBM) ... Australia, China, India and Japan. The report provides ... market forecasts until 2020. It also covers disease ...
Breaking Medicine News(10 mins):Health News:Study shows steep decline in tooth loss, increase in socioeconomic disparities 2Health News:Trinity Benefit Advisors is the Latest Firm to Join United Benefit Advisors 2Health News:Trinity Benefit Advisors is the Latest Firm to Join United Benefit Advisors 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 2Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 3Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 4Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 5Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 6Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 7
... Healthcare Access for All , , WASHINGTON, June ... Foundation (PAF) -- a national non-profit organization that seeks ... care, maintenance of employment and preservation of their financial ... debilitating diseases -- are in Washington, D.C. this week ...
... Inc., a developer of innovative therapies in women,s health, ... Coast Service Options, Inc. ("First Coast"), a large regional ... Puerto Rico and the U.S. Virgin Islands, has removed ... incontinence (SUI) from its noncovered services list and will ...
... /PRNewswire-FirstCall/ - AlphaRx Inc. (OTCBB: ALRX) releases letter to their shareholders: ... take a few minutes to update the current views on AlphaRx. ... last quarter with a small profit. Aside from the fact that ... one front. The events that occurred over the past few weeks, ...
... SignatureForum, a leading online source for consumer reviews ... the highest-rated cosmetic surgeons of the past year. The ... Providers group announced last month, is developed by processing ... United States and Canada. Rated on an overall scale ...
... to Treat Diseases (HTDS.PK) www.htdsmedical.com - announced ... recovering intellectual property (IP) rights that could provide an ... retained a USA based IP consultant to attempt to ... shareholder and its corporate advisors, verily believe was inappropriately ...
... YORK, June 24 Many Americans feel that today,s healthcare ... insurance premiums have made it more difficult to afford health ... resolution expert and physical therapist Mitchell Yass, is whether the ... believes they are not -- and what healthcare segment seems ...
Cached Medicine News:Health News:Patient Advocates From All 50 States Gather in Nation's Capitol to Meet With Lawmakers and Urge Passage of Comprehensive Health Care Reform 2Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 2Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 3Health News:AlphaRx Shareholder Update 2Health News:SignatureForum Reveals Top-Rated Cosmetic Surgeons in US 2Health News:Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership 2Health News:Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership 3Health News:One Man's Mission to Improve Our Healthcare System and Resolve Chronic Pain 2
(Date:8/20/2014)... Aug. 20, 2014 The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kansas blocked the sale of more ...
(Date:8/20/2014)... Aug. 20, 2014 PTC Therapeutics, Inc. (NASDAQ: ... upcoming investor conferences: - FBR 1 st ... Boston on Wednesday, September 3 rd ... Mandarin Oriental Boston on Thursday, September 4 th ... at the Bank of America Merrill Lynch Global Healthcare Conference ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... market research report is available in its ... Insurance in France, Key Trends and Opportunities ... Synopsis The report provides ... into the French personal accident and health ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2PTC Therapeutics to Participate at Upcoming Investor Conferences 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
... its inception in 1999, Clongen Laboratories, a CLIA ... has focused on improving human health by refining ... research services for pharmaceutical, biotechnology, government, and academic ... Clongen Laboratories uses in their Clinical Diagnostics Division ...
... NARBERTH, Pa, Nov. 15, 2011 As any purchasing manager ... and shipping options is time lost. When purchasing surgical ... In January of 2010, Robert Edelstein, President of ... Day Saints Charities seeking a vendor for eye surgical ...
Cached Medicine Technology:Clongen Laboratories Announces Formation of Separate Clinical Diagnostics and Contract Research Divisions 2Millennium Surgical Corp. Provides Instruments to Latter Day Saints Charities for Humanitarian Projects 2
... camera systems for optimum image quality ... digital camera system records live cells, ... fast exposure times at the lowest ... the visible spectrum assure reliable results ...
... U-III's compact, sleek design and ... sensor, make it the system ... applications including FISH. It is ... institutes and universities and wherever ...
Coolpix 5000 microscope package includes Coolpix 5000 digital camera, MDC-A relay lens, EH52 AC adapter, UR-E6 step-down adapter ring, EU-1 wired remote control unit....
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
Medicine Products: